key: cord-0911779-nz402xoq
authors: Mungmunpuntipantip, Rujittika; Wiwanitkit, Viroj
title: Perinatal outcomes of pregnant women with COVID-19
date: 2022-02-11
journal: Taiwan J Obstet Gynecol
DOI: 10.1016/j.tjog.2022.02.041
sha: d908b2b26f46e28907d728adc206952584b001b2
doc_id: 911779
cord_uid: nz402xoq

nan

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Rujittika Mungmunpuntipantip1, Viroj Wiwanitkit2 we would like to share ideas on "Perinatal outcomes of pregnant women having SARS-CoV-2 infection [1] ." Arinkan et al. concluded that "No significant difference was detected between groups in terms of the delivery …lower APGAR 5 scores [1] ." COVID-19 in pregnant woman is considered an important problem in obstetrics. The maternal COVID-19 mainly affects the pregnant mother since the transplancental transmission of disease is unlikely [2] . In the present study, Arinkan et al analyzed clinical outcome and assessed association with many obstetric parameter. An important consideration is the confounding factors that might affect clinical outcome. The classification as hospitalized and outpatient casee is rough and the severity according to WHO classification should be use for subgrouping. Reports on maternal outcome from different settings usually have different observation [3 -4] . Facilities for patient care might be an important determinant for outcome. Additionally, the treatment given to different cases might be different. Drugs given to pregnant mothers who are a hospitalized case might be different from drugs for those treated as outpatient cases. Nevertheless, effects of underlying disease and additional alternative therapeutic regimen might exist and should be further assessed.

Perinatal outcomes of pregnant women having SARS-CoV-2 infection

Comparative nanostructure consideration on novel coronavirus and possibility of transplacental transmission

Maternal and Neonatal Outcomes of Critically Ill Pregnant and Puerperal Patients Diagnosed with COVID-19 Disease: Retrospective Comparative Study

COVID-19 outcomes in hospitalized puerperal, pregnant, and neither pregnant nor puerperal women